Athens Medical Valuation
| IATR Stock | EUR 1.54 0.01 0.65% |
Based on Macroaxis valuation methodology, the firm appears to be fairly valued. Athens Medical CSA shows a prevailing Real Value of €1.54 per share. The current price of the firm is €1.54. Our model approximates the value of Athens Medical CSA from analyzing the firm fundamentals such as return on equity of 0.11, and Profit Margin of 0.06 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Athens Medical's price fluctuation is unstable at this time. Calculation of the real value of Athens Medical CSA is based on 3 months time horizon. Increasing Athens Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Athens Medical's intrinsic value may or may not be the same as its current market price of 1.54, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.54 | Real 1.54 | Hype 1.54 | Naive 1.55 |
The intrinsic value of Athens Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Athens Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Athens Medical CSA helps investors to forecast how Athens stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Athens Medical more accurately as focusing exclusively on Athens Medical's fundamentals will not take into account other important factors: Athens Medical Total Value Analysis
Athens Medical CSA is currently anticipated to have takeover price of 354.02 M with market capitalization of 145.28 M, debt of 129.39 M, and cash on hands of 4.59 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Athens Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
354.02 M | 145.28 M | 129.39 M | 4.59 M |
Athens Medical Investor Information
About 81.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.59. Some equities with similar Price to Book (P/B) outperform the market in the long run. Athens Medical CSA last dividend was issued on the 18th of August 2022. The entity had 2511:1034 split on the 8th of February 2000. Based on the analysis of Athens Medical's profitability, liquidity, and operating efficiency, Athens Medical CSA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Athens Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Athens Medical has an asset utilization ratio of 53.46 percent. This implies that the Company is making €0.53 for each dollar of assets. An increasing asset utilization means that Athens Medical CSA is more efficient with each dollar of assets it utilizes for everyday operations.Athens Medical Ownership Allocation
Athens Medical holds a total of 86.74 Million outstanding shares. Athens Medical CSA shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 80.82 percent of Athens Medical CSA outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Athens Medical Profitability Analysis
The company reported the revenue of 226 M. Net Income was 15.05 M with profit before overhead, payroll, taxes, and interest of 57.79 M.About Athens Medical Valuation
The stock valuation mechanism determines Athens Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Athens Medical CSA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Athens Medical. We calculate exposure to Athens Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Athens Medical's related companies.Athens Medical Center S.A., together with its subsidiaries, owns and operates hospital units in Greece and Romania. Athens Medical Center S.A. was founded in 1984 and is headquartered in Athens, Greece. ATHENS MEDICAL operates under Health Care Plans classification in Greece and is traded on Athens Stock Exchange.
8 Steps to conduct Athens Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Athens Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Athens Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Athens Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Athens Medical's revenue streams: Identify Athens Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Athens Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Athens Medical's growth potential: Evaluate Athens Medical's management, business model, and growth potential.
- Determine Athens Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Athens Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Athens Stock Analysis
When running Athens Medical's price analysis, check to measure Athens Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Athens Medical is operating at the current time. Most of Athens Medical's value examination focuses on studying past and present price action to predict the probability of Athens Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Athens Medical's price. Additionally, you may evaluate how the addition of Athens Medical to your portfolios can decrease your overall portfolio volatility.